Sensus Healthcare, Inc.
SRTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001494891
In the last 90 days, Sensus Healthcare, Inc. insiders filed 8 open-market purchases and 0 sales; 37 institutions reported holding it in 13F filings for Q3 2026, worth $10.8M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 14, 2026, 1:24 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $7.72M (28.1% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 5, 2025 | Feb 8, 2024 | Jan 9, 2023 | Jan 5, 2022 |
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M |
| Cost of revenue | $15.6M | $17.4M | $10.3M | $14.9M | $10.1M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M |
| Operating expenses | $22.2M | $16.3M | $14.4M | $14.8M | $12.9M |
| Research and development | $7.78M | $4.22M | $3.68M | $3.46M | $3.44M |
| Selling, general and administrative | $7.87M | $7.15M | $5.16M | $5.01M | $4.59M |
| Operating income | -$10.3M | $8.09M | -$382.0K | $14.8M | $4.12M |
| Interest expense | – | -$932.0K | -$992.0K | $2.00K | $2.00K |
| Income tax | -$1.91M | $2.38M | $167.0K | $3.75M | – |
| Net income | -$7.72M | $6.65M | $485.0K | $24.2M | $4.12M |
| EPS, basic | $-0.47 | $0.41 | $0.03 | $1.47 | $0.25 |
| EPS, diluted | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 |
| Weighted shares, basic | 16.3M | 16.3M | 16.3M | 16.5M | 16.5M |
| Weighted shares, diluted | 16.3M | 16.4M | 16.3M | 16.6M | 16.5M |
| Margins and growth | |||||
| Gross margin | 43.2% | 58.4% | 57.6% | 66.5% | 62.8% |
| Operating margin | -37.5% | 19.4% | -1.6% | 33.3% | 15.2% |
| Net margin | -28.1% | 15.9% | 2.0% | 54.4% | 15.2% |
| Revenue growth, year over year | −34.3% | +71.3% | −45.2% | +64.7% | +182.4% |
| Net income growth, year over year | −216.1% | +1,270.5% | −98.0% | +488.6% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 5, 2025 | Feb 8, 2024 | Jan 9, 2023 | Jan 5, 2022 |
| Cash and equivalents | $22.1M | $22.1M | $23.1M | $25.5M | $14.5M |
| Accounts receivable | $6.04M | $19.7M | $10.6M | $17.3M | $12.1M |
| Inventory | $14.6M | $10.1M | $11.9M | $3.50M | $1.76M |
| Total current assets | $45.9M | $56.7M | $49.5M | $53.2M | $31.2M |
| Property, plant and equipment | $1.98M | $2.00M | $464.0K | $243.0K | $605.0K |
| Intangible assets | – | – | – | $50.0K | $146.0K |
| Total assets | $53.0M | $62.2M | $53.7M | $56.7M | $32.2M |
| Total current liabilities | $4.72M | $5.88M | $4.21M | $7.70M | $5.96M |
| Total liabilities | $4.94M | $6.34M | $4.87M | $8.67M | $6.22M |
| Shareholders' equity | $48.1M | $55.8M | $48.8M | $48.1M | $26.0M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 5, 2025 | Feb 8, 2024 | Jan 9, 2023 | Jan 5, 2022 |
| Operating cash flow | $528.0K | -$831.0K | -$2.15M | -$1.41M | -$286.0K |
| Capital expenditures | $196.0K | $276.0K | $229.0K | $159.0K | $128.0K |
| Free cash flow | $332.0K | -$1.11M | -$2.37M | -$1.57M | -$414.0K |
| Depreciation and amortization | $400.0K | $239.0K | $275.0K | $315.0K | $613.0K |
| Stock-based compensation | $295.0K | $323.0K | $328.0K | $187.0K | $415.0K |
| Share buybacks | $300.0K | – | $27.0K | $3.00M | – |
| Investing cash flow | -$196.0K | -$276.0K | -$187.0K | $14.8M | $129.0K |
| Financing cash flow | -$305.0K | $15.0K | -$40.0K | -$2.43M | -$231.0K |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.1% | 0.8% | 1.3% | 0.4% | 1.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 10, 2026 | 16.5M | +0.2% | SEC |
| Aug 10, 2026 | 16.5M | +0.1% | SEC |
| May 6, 2026 | 16.5M | +0.1% | SEC |
| Feb 24, 2026 | 16.5M | −0.2% | SEC |
| Nov 5, 2025 | 16.4M | +0.2% | SEC |
| Aug 6, 2025 | 16.4M | +0.3% | SEC |
| May 6, 2025 | 16.4M | +0.3% | SEC |
| Feb 12, 2025 | 16.5M | +0.6% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.